chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On Saturday, July 31, 2021 client came to vaccination POD for his second Covid-19 Moderna dose. Upon arrival, front ancillary staff noticed that client was 13 years old and incorrectly vaccinated with Moderna Covid-19 vaccine. Per CDC guidelines, Moderna is authorized for use in individuals only 18 years old and up. Client's first Covid-19 Moderna dose (LOT #: 037C21A) was given by another organization on 06/30/21. According to a handout client's Mother received regarding the event, it states that a patient must be 12 years old to receive Pfizer vaccine with a  parent/guardian present. However after the error occurred, neither the parent or client was alerted of the mishap. Lead RN elevated to Operations Lead, who consulted with County MD. Per County MD approved and advised client to receive Pfizer Covid-19 vaccine as his second dose to complete the series, with no additional dose needed. Client has no history of allergies or previous adverse reactions to previous Moderna vaccine. Client was to be a 15 minute wait in the Observation Area. Client was vaccinated with Covid-19 Pfizer vaccine (LOT #: EW0183) in his left arm at 10:07 am. Client experienced no adverse reaction while waiting in Observation Area and left vaccination site with a steady gait at 10:35 am. VAERS completed on 7/31/21.
friends got sick,  after second dose; flu like symptoms; some couldn't go to work for a few days.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (friends got sick,  after second dose), INFLUENZA LIKE ILLNESS (flu like symptoms) and IMPAIRED WORK ABILITY (some couldn't go to work for a few days.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (friends got sick,  after second dose), INFLUENZA LIKE ILLNESS (flu like symptoms) and IMPAIRED WORK ABILITY (some couldn't go to work for a few days.). At the time of the report, ILLNESS (friends got sick,  after second dose) and INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown and IMPAIRED WORK ABILITY (some couldn't go to work for a few days.) had resolved.            No concomitant medication were given.  No treatment information were given.  Caller mention that their friends got sick, after second dose, like flu like symptoms ,and some couldn't go to work for a few days.
Pt previously received Pediarix and Rotarix on 5/9/23.  On 5/18/23 pt was given the vaccines again along with PedvaxHIB and Vaxneuvance.  No adverse outcome, no treatment needed
Dizziness, feeling like her throat was closing, trouble breathing, tunnel vision, a roaring sound in her head, weak, fast heart rate.
mild injection site pain; mild tiredness; minor aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A male patient received bnt162b2 (BNT162B2), administration date 02May2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose:1), for COVID-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 03May2021, outcome "unknown", described as "mild injection site pain"; FATIGUE (non-serious) with onset 03May2021, outcome "unknown", described as "mild tiredness"; PAIN (non-serious) with onset 03May2021, outcome "unknown", described as "minor aches".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After receiving the vaccine in fall/winter of 06, she contracted flu strain A in February of 2007 and flu strain B in March of 2007. The pediatrician and I believe the immunization to be a placebo or false immunization.
p/vax pt exp flu-like sx & joint swelling of the knees & fingers;sx resolved;
weak; coughing; lethargic; migrane; Patient received DOSE 3 (BOOSTER), SINGLE; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 77-years-old female (wife) patient received BNT162B2 (PFIZER BIONTECH COVID VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 29Sep2021 as DOSE 3 (BOOSTER), SINGLE (age at vaccination 77 years old) for covid-19 immunization. Patient's medical history included asthma, migraine both were from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient received previously first dose of BNT162B2 (PFIZER BIONTECH COVID VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on unspecified date as dose 1, single and second dose of BNT162B2 (PFIZER BIONTECH COVID VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on unspecified date as dose 2, single for covid-19 immunization and experienced lethargic, weak, went down after Dose 1 and Dose 2. The patient taken third dose of BNT162B2 on 29Sep2021 (Booster dose). On 29Sep2021, patient experienced weak, coughing, lethargic, and migraine. It was reported that 3 hours after the booster on 29Sep2021 patient experienced coughing (noting that the coughing was bad enough at 10 PM), patient experienced weak, lethargic, and woke up with a migraine. Patient received treatment with Tessalon Perles, Nyquil at 4 or 5 AM for coughing. Both of these medications helped. The outcome of events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Patient had her second shingrix and then that night the patient started to get the chills and her fever got up to 102.7, went down to 101 with tylenol. The patient also had body aches at this time. Patient stated that this prevented her from doing her regular activities and states she was very miserable.
Hives on my arms, stomach, buttocks, back of thighs, under my breasts, back.   I started itching around 10:30 AM. It became unbearable, that's when I decided to go to the ER. Benadryl, and steroids via IV, EpiPen injection and Pepcid via IV.
tachycardia, numbness and tingling, prickles, gripping sensations in chest and diaphragm that occasionally lead to burning icy hot /acid feeling, pain in different areas of front torso, episodic tachycardia, burning/ hot flashes, weight loss associated with this, occasional pain under right ribs when eating, sensitive to temperature fluctuations, especially cold, easily chilled after episodes.  These symptoms have persisted for 7 months since vaccination with periods of wax and wane and fluctuating severity  multiple treatment trials ranging from integrative treatments using nutriceuticals, Medicine formulas, as well as conventional treatments including antihistamine therapies,  15 day course of prednisone
Information has been received from a licensed practical nurse concerning several patients who were vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Subsequently, the patient experienced a knot that formed at the injection site. The patient's knot that formed at the injection site persisted. Additional information has been requested.
I developed upper abdominal discomfort/pressure that moved into the anterior part of my chest and then up to my neck. It was mild to moderate. It resolved after 1000 mg of Tylenol and did not return.
flu; This spontaneous report has been received from a lawyer, for zoster vaccine live (ZOSTAVAX) (MARRS # 2108USA004563), concerning a patient of unknow age and gender. The patient's medical history included smoking user and chickenpox.    On an unspecified date in 2017, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(manufacturer unknow) (dose, unit, route of administration, lot # and expiration date were not reported) for prophylaxis. On an unknown date, the patient got a really bad flu. The outcome of the ebvent was unknown. The event was considered to be related to pneumococcal vaccine, polyvalent (23-valent)(manufacturer unknow).; Sender's Comments:  US-009507513-2108USA004563:
This is a spontaneous report from contactable consumer reporting for herself. A 77-year-old female patient (not pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6206) on 12Mar2021 at 10:00 at single dose via an unspecified route of administration on left arm for COVID-19 immunization. Relevant medical history included COPD, Lupus, Contrast media allergy. The patient received first dose of BNT162B2 (UEN 6201) on 19Feb2021 at 14:00 on left arm. Concomitant medications included metoprolol, prednisone, amlodipine. On 13Mar2021 at 02:00 the patient experienced pyrexia, nausea, vomiting, diarrhea. No Treatment was received for the event. At the time of the reporting the patient had not yet recovered from the events. No follow-up attempts are possible. No further information is expected.
Adverse event includes red, warm and itchy around the injection site of Prevnar 13.
Developed redness, some edema at injection site then fever 104 between 24-48 hours after vaccine.
Medical assistant calling with MIR related to a patient that received both PROQUAD and VARIVAX on the same day; Medical assistant calling with MIR related to a patient that received both PROQUAD and VARIVAX on the same day; No additional AE information; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On an unknown date, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection, site of administration reported as leg, lot number: U025202, expiration date: 13-AUG-2023 and Measles, Mumps, Rubella and Varicella (Oka-Merck) site of administration reported as leg, Virus Vaccine Live (rHA)(PROQUAD) subcutaneous injection lot number T037955, expiration date: 09-MAY-2022 (strength, dose, dose number, route of administration for both suspect vaccines were not reported) for prophylaxis (inappropriate schedule of product administration, overdose). It was reported that each suspect vaccine was given in a different leg. No additional adverse information was reported (no adverse event).
Pt indicated it was warm to touch, itches, slightly tender and feels like a big bruise.
Patient received 2nd dose of Moderna vaccine on 3/23/21 at facility; she has received 1st dose of Moderna vaccine on 2/23/21.  Patient was fully vaccinated. Patient tested positive for COVID-19 on 7/29/21.
Pt complained of pain in chest on second day after getting second Pfizer Vaccine and at 2:00 AM got out of bed walked to bathroom and when he got up from toilet collapsed and died on floor. He is a citizen, he was retired.
? PT received Booster dose of Pfizer Friday evening @1900. ? No reaction most of weekend, feeling cold Sunday (17Oct2021) afternoon, symptoms improved. ? @1200 Monday 18 October 2021, while working, PT reported to Observation Lead feeling chilly.  ? @ 1225 Safety was notified PT was feeling ill. ? PT escorted to Screened Observation area. ? PT reported shifting feelings of cold & feeling feverish throughout body, core & peripheral. ? Onset of headache, rhinorrhea, fatigue. ? PT Hx of Asthma, no (current) trouble breathing/ exacerbation of condition. ? No hx allergies: food, med. ? @ 1230 BP: 166/90  ? @1236 PT expressed they wanted evaluation by EMS. ? @1240 Site Director initiated emergency call. ? @1245 BP: 171/92, PR: 91, PT reported no improvement in condition. ? @1252 EMS onsite, EMS Evaluation ? @1253, BP: 164/86, PR: 88 ? @1259 BP: 146/107, PR: 91 ? @1300 PT declined transport.  Decided to go home to rest & recover.  ? @1310 PT left for the day voluntarily, ambulatory, AOx4, and stable. ? PT will follow up with Dr.
Severe soreness to right shoulder resulting in difficulty lifting and rotating arm clockwise. went to dr. 3 weeks later, used a steroid pack prescribed by md and NSAIDS, MRI WNL.
Patient thought they were getting a Prevnar 20  but got a Prevnar 13 instead
Three days after vaccination started having an elevated heart rate and blood pressure that lasted about 10 days.
This spontaneous report as received from a 75 year old female patient with high blood pressure, high cholesterol, arthritis and no known drug reactions/allergies. The patient's medical history included shingles. In July 2013 the patient was vaccinated with a dose of ZOSTAVAX (dose, route and lot number not provided) for shingles vaccination. The patient got the ZOSTAVAX after she had the shingles. Concomitant therapies included CELBREX and unspecified triglyceride. In July 2013 the patient developed a small knot around the injection site. No treatment was given for the adverse event. No lab diagnostic tests were performed. The patient sought the physician for medical attention. The outcome of the event was reported as recovered (approximate date 2013). The causal relationship was not reported. Additional information has been requested.
loss of appetite, nausea, diarrhea, within 1st day.  passed out on day 6 - cardio Dr said was an effect of low insulin levels. By day 9 she was having difficulty breathing.  Was admitted to hospital that day for oxygen.  5 days after entering hospital was placed on ventilator.  Died 14 days later.
Same day loss of energy, next day scratchy throat, body aches, head spinning, disoriented, slight nuasea, making mistakes at work, easily upset (angry). Asked to sent home early.
This is a spontaneous report from a contactable consumer (patient). This 78-year-old patient of an unspecified ethnicity and gender received PREVNAR 13, via an unspecified route of administration at single dose on an unspecified date for immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced a severe allergic reaction left arm very painful and bright red from the injection site to the elbow, headache, fatigue, dizziness, weakness, confused thinking, had the first fall, this resulted in an injury to a leg. The outcome for all events was unknown.
shortness of breath, headache, chest pain, dizziness poor cognition started less than 24 hours after vaccine #1.    Sx persisted for several weeks and he presented to the ER.   Complete work up done at the ER (except for D dimer was never done).   No heart attack or abnormal EKG.   He was treated and released.     Still reports daily headaches,  brain fog and dizziness in the am,  left arm pain and weakness.     Pt has refused the take the second shot in the series.
Morning after 2nd dose: Tiredness/ fatigue,  chills, muscle soreness, joint pain and stiffness. Lasted about 36 hours.  Took naproxen 375 mg which seemed to help
Hello, I am a pharmacist and today we were administering Moderna. Pharmacy staff failed to verify age of greater than 18 and I just walked in and administered. Patient is a 15 year old female. No adverse effects have occurred at this time. Need guidance on what needs to be done i.e. with regard to the second dose.
first noticed pain 9/10, quality: aching, patient took tylenol, took two tylenol, eased pain, at night, developed cold, mouth felt bitter, pt knew he had a fever, could not sleep, covered himself with blankets, took flomax with frequent urination, in am on 7/1/2010, lost appetite, drank water and hot tea, still had fever, swelling in arm redness 34 cm x 20 cm, pain with flexion of elbows with pruritus
Patient is reporting a shingles outbreak on the right side of his neck. This started on 12/15/19 about 45 days after his first dose of Shingrix
p/vax pt devel varicella w/6 lesions;MD visit required;
DVT Left lower extremity, pain developed about 10 days after vaccine, diagnosed 4/19/21 on Ultrasound, no prior history
diarrhea, vomiting; rash tha came & went around neck & diaper area; tired; no blood in stool; poor appetite; no headache; no seizures; seen by MD:
itching at front and back of neck and scalp; itching inside his left arm where he got the injection; Headache; elevated body temperature; itching at his chest; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching at his chest), PRURITUS (itching at front and back of neck and scalp), BODY TEMPERATURE INCREASED (elevated body temperature), VACCINATION SITE PRURITUS (itching inside his left arm where he got the injection) and HEADACHE (Headache) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included HYDROCHLOROTHIAZIDE and SIMVASTATIN for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PRURITUS (itching at his chest), BODY TEMPERATURE INCREASED (elevated body temperature) and HEADACHE (Headache). On 21-Feb-2021, the patient experienced PRURITUS (itching at front and back of neck and scalp) and VACCINATION SITE PRURITUS (itching inside his left arm where he got the injection). At the time of the report, PRURITUS (itching at his chest), PRURITUS (itching at front and back of neck and scalp), BODY TEMPERATURE INCREASED (elevated body temperature), VACCINATION SITE PRURITUS (itching inside his left arm where he got the injection) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Feb-2021, Body temperature: elevated.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This spontaneous report as received from a nurse refers to a 6 months 11 days old male patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) oral, ROTATEQ lot # K016313, exp. date: 31-MAY-2016 and lot # K011663, exp. date: 20-MAY-2016 (dose and strength unspecified) oral. No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
Collapsed. Woke up to use bathroom & as I was returning to bed, I felt as if I was heavily drugged & hanging onto the wall I finally collapsed banging my head on the wall. I was helped by my husband to get back into bed. He had me drink lots of water.  I eventually fell back to sleep & felt fine when I woke up.
Meningococcal MCV4 LOT# U3433AA - Exp. 08/02/11 vaccine administered 8/10/11, 8 days after expiration date. Dose not re-administered.
misreport of administration of vaccine or potential error stated by patient on 01/11/2021.
This case was reported by a healthcare professional and described the occurrence of strange test in an adult subject of unspecified gender who was vaccinated with Fluarix (GlaxoSmithKline). Previous and/or concurrent vaccination included DTaP; manufacturer unspecified given on 9 December 2007; hepatitis B vaccine recombinant; manufacturer unspecified given on 9 December 2007; hepatitis A vaccine inactivated; manufacturer unspecified given on 9 December 2007. On 9 December 2007 the subject received unspecified dose of Fluarix (.5 ml, unknown) intranasally (intramuscular formulation administered by other route) and experienced a funny taste. The same day, the subject was later vaccinated with Fluarix and experienced accidental overdose. No other adverse events were reported. In December 2007, the events were resolved. Outcome of accidental overdose was not specified. The healthcare professional considered the events were probably related to vaccination with Fluarix (causality not provided for accidental overdose). Follow-up information received on 14 January 2008 indicated that the intramuscular formulation of vaccine was mistaken as "Flumist" and administered intranasally. There were no other adverse events other than "bad taste."
shingles; other zoster-related conditions; Information has been received from a lawyer regarding a case in litigation and refers to a patient of unspecified age and gender. The patient's concurrent conditions, concomitant medications and medical history were unknown. On or about 15-JAN-2013, the patient was inoculated with zoster vaccine live (ZOSTAVAX), as prescribed and/or administered by a healthcare provider (HCP) for the long-term prevention of shingles and zoster-related conditions. Subsequent to the patient's zoster vaccine live (ZOSTAVAX) inoculation (unspecified date), the patient was treated by a physician for shingles and other zoster-related conditions(ill-defined disorder). As a direct and proximate result of the zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of shingles and other zoster-related conditions was not recovered. The lawyer considered shingles and other zoster-related conditions to be related to zoster vaccine live (ZOSTAVAX).
On the day of the vaccine at 11:00 PM started had a lymph node under her left arm that swelled up and got sore.  Her arm felt like somebody ripped off.  Fever of 102.6 the following day, and all through the day.  The fever did not break until Monday on 2/1/21.   It also made her quesey and ate crackers and apple sauce.  These symptoms lasted through Tuesday.  She ended up working 1/2 day on Tuesday due to exhaustion.  By Wednesday 2/3/21 got her energy back.  Today she is better, feels good.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The patient was vaccinated with improperly stored PNEUMOVAX 23 on 31-AUG-2012. Lot # was reported as 0709AE, expiration date: 04-JAN-2014. Route was unspecified. No adverse events reported. The vaccine storage information was reported as "From 14-AUG-2012 to 28-AUG-2012, lowest temp excursions at -8.3C for total of 9 hours (2 excursions), -3.6C for total of 19 hours (2 excursions), 04.8C for total of 12 hours (4 excursions) and -5.7C for total of 9.5 hours (2 excursions). High temp excursion exposed to 18.4C for 1 hour and 10 minutes." This is one of several reports received from the same source. 1209USA007525 1209USA008597 1209USA008598 1209USA008599 1209USA008600 1209USA008601 1209USA008602 1209USA008603 1209USA008604 1209USA008605 1209USA008606 1209USA008608 1209USA008609 1209USA008610 1209USA008611 1209USA008612 1209USA008613 1209USA008614 Additional information has been requested.
Kinrix vaccine was given to patient  in error . Patient should have only received DTAP (infarix) . Patient is not having any side effects or symptoms to the vaccine